Back to results
US 8,911,768 B2Granted
Methods for treating retinopathy with extended therapeutic effect
AssigneeAllergan, Inc.
InventorsScott M. Whitcup, David A. Weber
Life of this patent
Estimating the term…
Abstract
Methods for treating and preventing retinopathic conditions by administering an anti-VEGF compound to the vitreous chamber of a patient at risk of, or suffering from, the retinopathy.
Claims3
An ocular implant for treating macular degeneration comprising an active agent and a carrier associated with the active agent, wherein the carrier comprises a 30/10 w/w mixture of hydrophilic end PLGA and hydrophobic end PLGA, wherein the active agent is ranibizumab and wherein the implant is formed by an extrusion method.
Dependencies are inferred from the claim text.